CTSO News and Press, CytoSorbents Corporation From 06/24/25

CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR PR Newswire PRINCETON, N.J. , June 24, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening c...

CytoSorbents to Participate at the Jefferies Global Healthcare Conference PR Newswire PRINCETON, N.J. , May 29, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care un...

CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025 PR Newswire Real-World Analysis Shows Statistically Significant Reduction in Severe Bleeding and Transfusion Needs in CABG Patients on the Blood Thin...

2025-05-14 21:38:35 ET More on Cytosorbents Cytosorbents Corporation (CTSO) Q1 2025 Earnings Call Transcript Cytosorbents Corporation (CTSO) Q4 2024 Earnings Call Transcript Cytosorbents Non-GAAP EPS of -$0.06, revenue of $8.73M misses by $0.28M Cytosorbents ...

2025-05-14 21:37:47 ET Cytosorbents Corporation (CTSO) Q1 2025 Earnings Conference Call May 14, 2025, 04:30 PM ET Company Participants Adanna Alexander - Investor Relations Phillip Chan - Chief Executive Officer Makis Deliargyris - Chief Medical Officer Pete ...

2025-05-14 16:30:02 ET More on Cytosorbents Cytosorbents Corporation (CTSO) Q4 2024 Earnings Call Transcript Cytosorbents outlines 2025 growth strategy with $1B market potential for DrugSorb-ATR Seeking Alpha’s Quant Rating on Cytosorbents Historical e...

CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update PR Newswire PRINCETON, N.J. , May 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the inte...

Aeva Technologies Inc. (AEVA) is expected to report $-0.59 for Q1 2025 Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil) (LND) is expected to report for Q3 2025 Omron Corporation ADR (OMRNY) is expected to report for Q4 2025 Sezzle Inc. (SEZL) is expected to report $0.3...

2025-05-13 18:48:10 ET Cytosorbents Corporation (CTSO) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 6.70%. The average open to low on the day of earnings was -7.56%. The average open ...

2025-05-13 18:43:09 ET Cytosorbents Corporation (CTSO) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in CTSO stock price following earnings has averaged ±4.63% , with a median of 1.97%....